Not applicableStudy completedNCT00386373What this trial is testingUse and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsWho this might be right forLeukemia M.D. Anderson Cancer Center 10
Not applicableEnded earlyNCT01169753What this trial is testingNuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia PatientsWho this might be right forChronic Myeloid Leukemia M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05092451What this trial is testingPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesWho this might be right forB-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT00055653What this trial is testingDonor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00357305What this trial is testingVorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00002792What this trial is testingCombination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07238712What this trial is testingOptimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorWho this might be right forAcute Myeloid Leukemia (AML)Chronic Myeloid LeukemiaMyelodysplastic Syndromes (MDS)+2 more St. Petersburg State Pavlov Medical University 60
Not applicableStudy completedNCT01233921What this trial is testingPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more Martin, Paul 6
Testing effectiveness (Phase 2)Looking for participantsNCT06514534What this trial is testingOpen-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.Who this might be right forChronic Myeloid Leukemia (CML) Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01460693What this trial is testingComparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid LeukaemiaWho this might be right forMyeloid Leukemia, Chronic, Chronic Phase Newcastle University 814
Testing effectiveness (Phase 2)Study completedNCT00001873What this trial is testingThe Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Ended earlyNCT01650805What this trial is testingPonatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)Who this might be right forChronic Myeloid Leukemia Ariad Pharmaceuticals 307
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006475What this trial is testingSTI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast CrisisWho this might be right forLeukemia Novartis
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982What this trial is testingCombination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT00982488What this trial is testingLong-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Bristol-Myers Squibb 238